Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 35.45
+2.37 (7.16%)
At close: Nov 5, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 3.51 billion as of November 5, 2026. It is the 14,547th most valuable company in the world and the 3,882nd biggest in China. Its market cap has decreased by 26.45% in one year.
Market Cap
3.51B
Enterprise Value
2.89B
Revenue
82.85M
Global Rank
Country Rank
#3,882 China
PE Ratio
n/a
ChartMarket Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 3.51B, an increase of 17.77%. That is a compound annual growth rate of 3.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 3.51B | -27.90% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 3.19B |
| Shanghai Serum Bio-Technology | 3.16B |
| Jiangsu Sihuan Bioengineering | 3.13B |
| Kexing Biopharm | 3.00B |
| Xiangxue Pharmaceutical | 2.94B |
| Shanghai Shen Lian Biomedical | 2.93B |
| Qingdao Vland Biotech INC. | 2.92B |
| Lifecome Biochemistry | 2.85B |